R650,00
Accelerated Healing, Reduced Inflammation, Scarring and Fibrosis Relief, Heart and Organ Protection, Eye Health, Rejuvenation of Tendons, Ligaments, Wounds, and Cartilage.
R650,00
7 in stock
TB-500 is a lab-made synthetic peptide – a super-short chain of just 7 amino acids copied from the active ‘repair’ section of a natural 43-amino-acid protein called Thymosin Beta-4 (Tb4). Your body already makes Tb4 in almost every cell (highest in platelets and wound fluid) to kick-start healing after injury. Researchers created the tiny TB-500 fragment because it’s cheaper, more stable, and easier to produce while keeping the key healing powers.
Picture TB-500 as your body’s ‘mobile repair squad commander.’ It tells cells to move to the damage site, build new blood vessels, and fix tissue without excessive scarring.
How it works:
– Binds to actin (a protein that shapes cells) unlocks cell migration, proliferation, and differentiation so repair cells rush in fast.
– Sparks angiogenesis (new tiny blood vessels) for oxygen/nutrients.
– Calms inflammation (downregulates NF-B), stops cell death (anti-apoptosis), and reduces scar-forming myofibroblasts.
– Mobilizes stem/progenitor cells and protects organs.
TB-500 (and full Tb4) shows an excellent short-term safety profile in animal and early human studies – no major toxicities even at higher doses.
In human trials (mostly full Tb4): Well-tolerated; no dose-limiting issues or serious events.
Reported mild/rare effects (anecdotal + trial data):
– Injection-site reactions (redness, mild swelling, itching).
– Headache, fatigue, dizziness, or temporary ‘head rush.’
– Mild nausea or flu-like feelings (rare).
Bottom line: Appears very well-tolerated short-term under supervision, but you’re still in experimental territory.
Reconstitute 2ml of bac water into 10mg vial. See Reconstitution Guide
Dosing and Cycling:
No official guidelines (not approved), so these are common research/clinic protocols scaled from animal data and user reports.
Typical dose:
2.5mg per week. Draw 50 units (0.5 ml) from reconstituted vial. Twice a week and the morning. 10mg lasts 4 weeks. Double dose if necessary for more severe cases. See Peptide Calculator
Subcutaneous (under skin) injection – can be systemic (belly) or near the injury for targeted effect. Some use intramuscular.
Cycling:
4-6 weeks on (or until healed), then 2-4 weeks off; some do 3 months on + 1 month off.
For acute injuries: Use during recovery phase only.
Often combined with BPC-157 for synergy.
Tip: Reconstitute with bacteriostatic water; store in fridge. Sterile technique essential.
– Your body’s built-in first responder – Ta4 is released instantly from platelets at any injury site (it’s one of the most abundant proteins in wound fluid).
– Embryonic repair mode – it helps ‘remind’ adult tissues how they healed perfectly as a fetus, reducing scars.
– Horse-racing origins – vets first used it on racehorses for tendon/ligament injuries; athletes noticed and it exploded in popularity.
– Metabolite magic – recent 2024 research suggests the real hero might be a tiny breakdown product (Ac-LKKTE), not the full TB-500.
– Wolverine stack legend – paired with BPC-157 it’s nicknamed after the X-Men character because injuries heal ridiculously fast in animal studies.
– Everywhere protein – Ta4 is in every tissue except red blood cells – one of the most widespread healing molecules we have.
– Short but mighty – the 7-amino-acid version is cheaper and more stable than the full 43-aa natural version.
1. Sosne et al. (2015) Phase 2 randomized trial: T?4 eye drops for severe dry eye (n=~72). 35% less discomfort + 59% less corneal staining vs placebo at 56 days; safe.
2. Wang et al. (2021) Phase 1 safety study: Recombinant T?4 IV in 84 healthy volunteers. Well-tolerated at single/multiple doses; no serious adverse events or accumulation.
3. Zhu et al. (2016) Pilot: T?4-pretreated stem cells in heart attack patients. Improved cardiac function/exercise capacity at 6 months; safe.
4. NCT00832091 (completed 2009) Phase 2: Topical T?4 gel for venous stasis ulcers (dose-response, placebo-controlled). Safe; some patients showed faster wound closure (up to ~1 month earlier in small/moderate ulcers).
5. Philp et al. (2003) Mouse study: Synthetic 7-aa TB-500-like peptide accelerated wound healing in normal, diabetic, and aged mice (comparable to full T?4).
6. Goldstein et al. (2012) Review: T?4 as multi-functional regenerative peptide – mechanisms, angiogenesis, reduced scarring, clinical applications.
7. Xing et al. (2021) Comprehensive review: T?4 in heart disease, wound healing, inflammation; strong preclinical + emerging human data.
8. Rahaman et al. (2024) Metabolism study: TB-500’s wound-healing effects may actually come from its metabolite (Ac-LKKTE); important nuance.
9. Innerbody Research (updated Jan 2026) Summary: Overview of TB4/TB-500 trials for eyes, heart, wounds; safety profile excellent.
10. Peng (March 2026) Clinical review: Musculoskeletal applications – promising animal data, early human signals; calls for more RCTs.
Takeaway: Exciting preclinical healing data + proof-of-concept in human eye/heart/wound trials, but we need big musculoskeletal RCTs for TB-500 specifically.
Autoimmune Boost, Viral Relief, Vaccine Booster, Inflammation, Anti-Aging, Post Viral Fatigue.
R650,00
Neuroprotection, Cognitive Enhancement, Memory, Learning Speed, Focus, Anti-Aging, Brain Support, Neuroinflammation, Strong Sleep Aid.
R590,00
Gut Healing, IBD Support, Intestinal inflammation Reduction, Skin Health, Wound Repair, Antimicrobial, Immunity, Powerful Systematic Anti-Inflammatory.
R480,00
Powerful Detoxification, Liver Protection, Immunity Enhancer, Anti-Inflammatory, Skin Brightener, Skin Health, Anti-Aging, Cellular Repair, Clear Toxins.
–
R850,00
Neuropathic Pain Relief, Anti-inflammatory effects, Tissue protection, Healing, Fatigue, Quality of Life.
R550,00
Rapid Healing (Ligaments, Joints, Cartilage), Gut Repair, Pain and Inflammation, Nerve and Brain Protection, Blood Vessel and Organ Protection.
R550,00